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Introduction
A paradigm of the metazoan body plan is the combination of epi-
thelial and mesenchymal elements into structured three-dimen-
sional organs. Fibroblasts are cells that synthesize and integrate 
structural proteins such as collagen and elastin into the extracel-
lular matrix (ECM) of most mesenchymal tissues (1–4). It has long 
been believed that fibroblasts exhibit differing functional iden-
tities (5), and in recent years, evidence has emerged to support 
this concept. Fibroblasts are characterized by the expression of 
markers including vimentin and procollagen Iα2 chain (1). How-
ever, these markers are not considered specific for fibroblasts (6), 
and it has not been demonstrated that they are expressed on all 
fibroblast types.
Fibroblast heterogeneity can be considered according to stage 
of development, tissue of origin, or tissue microenvironment. 
The mammalian skin has proven a particularly tractable tissue in 
which to address these questions. The epidermis, a stratified squa-
mous epithelium, overlies the dermis, a mesenchymal tissue (Fig-
ure 1). In addition to fibroblasts and ECM components, the der-
mis, in common with other mesenchymal tissues, incorporates a 
wide range of other cell types, including blood vessel components 
(endothelial cells, smooth muscle cells, and blood vessel–associ-
ated fibroblasts) (7), eccrine and apocrine sweat glands, lymphatic 
vessel components, neurons (8), sensory receptors, and tissue-res-
ident immune cells (9, 10). These other cell types are sufficiently 
numerous that fibroblasts represent a minority cell population in 
the adult dermis.
A simple definition of cellular identity is that it represents the 
set of macromolecules present within a cell at a specific point in 
time. However, this definition omits the possibility that cells with 
identical gene expression patterns at a particular time point can 
respond differently to an external stimulus or differentiate sponta-
neously because of epigenetic or other factors. A further complica-
tion is that spatial location with respect to ECM components and 
other cells may play a role in the maintenance of a specific cellu-
lar identity, and these signals can be lost when cells are extracted 
from the tissue. As a consequence of these factors, the dissection 
of cellular identity and lineage relationships is inherently more 
challenging for cells that constitute solid tissues than for cells of 
the hemopoietic system.
Here, we discuss emerging concepts relating to cellular identi-
ty and lineage relationships of fibroblasts. We begin by discussing 
fibroblast heterogeneity according to tissue and anatomical site of 
origin. Subsequently, we examine evidence in support of the con-
cept that individual tissues, such as the dermis, comprise multiple 
fibroblast subtypes. We consider to what extent differences are 
specified intrinsically by transcriptional regulatory networks and 
epigenetic mechanisms versus by extrinsic factors that depend on 
the spatial context within the tissue, such as secreted factors, cell-
cell communication, and interactions with the ECM.
While full details of the mechanisms governing fibroblast 
cellular identity remain to be determined, it is likely that specif-
ic fibroblast subtypes will play key roles in wound healing, in dis-
eases characterized by excessive fibrosis, in cancer stroma, and 
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(15) are correlated with differing patterns of Hox gene expression 
that reflect the developmental origin of the cells (16, 17). There-
fore, differences in the behavior of fibroblasts from different 
body sites likely reflect a combination of intrinsic differences and 
the role of factors such as mechanical stress that differs between 
body regions (22).
Fibroblasts derived from the bone marrow, which are the cells 
that adhere when plated in culture, are worthy of special consid-
eration. This population of fibroblasts have the capacity to dif-
ferentiate into multiple lineages (23) and have been termed mes-
enchymal stem or stromal cells (MSCs). Initial reports suggested 
that MSCs can contribute to the dermis (24–26), but subsequent 
studies do not appear to support this finding (27–29). Interesting-
ly, clinical trials have suggested that the infusion of MSCs into the 
blood may ameliorate several diseases, such as graft-versus-host 
disease (30, 31). However, there has been no demonstration that 
these MSCs stably engraft, and it has been proposed that any ben-
eficial effects are achieved by release of paracrine factors (32).
Recent results support the concept that pericytes — blood ves-
sel–associated fibroblasts — are the in vivo counterpart of MSCs 
(33). Pericytes are associated with and encircle vascular channels in 
most tissues (34, 35). A number of markers have been proposed for 
the identification of pericytes, including NG2 (35) and RGS5 (36). It 
remains unclear whether different subtypes of pericytes are associ-
ated with arteries, veins, and lymphatics. Within muscle, it appears 
that pericytes have the capability to differentiate to muscle fibers 
(37), but at the present time there is no evidence that pericytes have 
the capability to differentiate into other dermal lineages. A specific 
subset of ADAM12-expressing perivascular fibroblasts present in 
skin and muscle are activated by wounding and contribute to colla-
gen overproduction in the scar (38). Genetic ablation of these cells 
reduces collagen production and scarring (38).
Cardiac fibroblasts constitute the largest cellular population 
within the heart (11) and are located throughout the myocardi-
um, interspersed between myocardiocytes (11). They exhibit spe-
cific expression of discoidin domain receptor 2 (DDR2) (39) and 
play a critical role in the regulation of normal myocardial func-
tion in addition to the pathological remodeling that accompanies 
hypertension and heart failure. It has long been recognized that 
the effects of angiotensin II signaling on cardiac fibroblasts and 
myocytes lead to hypertrophy and fibrosis (11). Proinflammatory 
signaling by IL-1β and TNF-α also leads to pathological alterations 
in collagen synthesis by cardiac fibroblasts that accompany myo-
cardial failure (40). Fibroblasts are also integral to the structure 
of the lung, and, as for the heart, the effects of proinflammatory 
cytokines such as IL-1α on pulmonary fibroblasts play an import-
ant role in the progression of fibrotic lung disease (41).
potentially in tissue aging. This suggests the possibility that in vivo 
inhibition of specific fibroblast subtypes or cellular therapy con-
sisting of ex vivo expansion and subsequent reintroduction may 
have therapeutic benefit in the treatment of such conditions.
Fibroblast heterogeneity according to 
anatomical origin
Mesenchymal-derived connective tissues including heart (11), 
lung (12), gastrointestinal tract (13), and muscle (14) contain 
fibroblasts that fulfill specialized functions (15). Differences in 
gene expression have been demonstrated between dermal and 
nondermal fibroblasts (16, 17), and fibroblasts derived from dif-
ferent anatomical sites have differing developmental origins, 
including the neural crest, lateral plate mesoderm, and dermato-
myotome (18–20). Moreover, there are significant differences in 
the architecture of the dermis at different body sites, which are 
associated with a differing potential for disease processes such as 
the formation of keloid scars (21). Differences in morphology and 
behavior in cultured fibroblasts derived from different body sites 
Figure 1. Structure of murine dorsal skin. The skin has two layers, 
the epidermis and the dermis. The epidermis is a stratified squamous 
epithelium with associated adnexal structures such as hair follicles and 
sebaceous glands. It is separated from the underlying connective tissue, 
the dermis, by a basement membrane (red). The three dermal layers are 
the papillary dermis (PD), reticular dermis (RD), and hypodermis/white 
adipose tissue. The dermal papilla and arrector pili muscle constitute 
two specialized populations of dermal mesenchymal cells. Adapted with 
permission from Science (143).
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Fibroblast identity differs between 
papillary and reticular dermis
The mammalian dermis represents an 
archetypal mesenchymal tissue largely com-
posed of ECM elements, primarily type I and 
type III collagens, but also other collagen 
subtypes, proteoglycans, and elastin (4). It 
serves as a structural scaffold, and a base-
ment membrane enriched in type IV colla-
gen (44) separates it from the epidermis, a 
stratified squamous epithelium that forms 
the outermost layer of the skin. The dermis 
is penetrated by numerous appendageal 
structures, including hair follicles and sweat 
glands, which manifest as specialized invag-
inations of the epithelium, for which the 
basement membrane is in continuity with 
the interfollicular epidermis (Figure 1). The 
detailed microstructure of the dermis differs 
between human and mouse skin. In humans, 
there is a relatively low density of hair folli-
cles on body sites outside of the scalp, with 
intervening interfollicular epidermis exhib-
iting invaginations known as rete ridges. In 
mice, the density of hair is higher and rete 
ridges are not prominent (Figure 2).
The dermis has distinct layers that are 
readily identified histologically: the pap-
illary dermis is the superficial layer of the 
dermis that lies immediately below the 
epidermis (Figure 1). This is composed of 
dense but poorly oriented collagen bundles 
that provide structural support to the over-
lying basement membrane (4). Beneath this 
layer is the reticular dermis, which compris-
es directionally oriented, thicker collagen 
bundles with intervening spaces (45, 46). 
It has long been recognized that there are 
differences in the composition of the ECM 
components at the ultrastructural level that 
constitute the papillary and reticular der-
mis. This has led to the hypothesis that ECM 
composition reflects differences in fibro-
blast identity in the tissue compartments.
Microarray analysis of cultured fibro-
blasts derived from mechanically separat-
ed dermis has revealed differences in gene 
expression (47); however, subsequent stud-
ies have yet to reproduce proposed markers 
of papillary and reticular layers. Dermatome experiments of this 
nature are inherently limited, since the level of sectioning cannot 
be precisely controlled, and therefore the possibility that reticular 
fibroblasts are included in the papillary sample cannot be exclud-
ed. Furthermore, since they are studied in the form of explant cul-
tures, it is not clear to what extent in vitro selection for specific cell 
subpopulations plays a role and to what degree blood vessel–asso-
ciated fibroblasts, known as pericytes, contribute.
Thus far we have considered differences in fibroblasts arising 
from distinct anatomical sites; however, as we shall discuss, multi-
ple, functionally distinct fibroblast subtypes can arise from a single 
tissue. This is best understood in the dermis. Although fibroblast 
heterogeneity in other organs has yet to be investigated in detail, 
it seems likely that it exists. For example, fibroblasts derived from 
kidney cortical and medullary regions exhibit differences in cell 
culture and in their responses to mitogenic stimulation (42, 43).
Figure 2. Comparison of human and murine skin. The interfollicular epidermis and dermis are thicker 
in human than in mouse skin. In most body sites mice possess a higher density of hair follicles. In 
human skin the boundary between the epidermis and dermis undulates, whereas it is flat in mouse 
skin. Adapted with permission from Cold Spring Harbor Perspectives in Biology (4).
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papillary fibroblasts, reticular fibroblasts, 
and dermal papillae are derived from a 
multipotent mesenchymal progenitor that 
is present at embryonic day 12.5 (E12.5), 
with lineage commitment occurring by 
E16.5 (56). At postnatal day 2, papillary, 
reticular, and hypodermal markers can be 
differentiated according to the expression 
of cell surface markers including CD26, 
SCA1, and DLK1, with CD26 marking the 
upper dermal lineage (ref. 56 and Fig-
ure 3). Papillary fibroblasts are required 
for new hair follicle formation following 
wounding, whereas reticular fibroblasts 
mediate the early events in wound repair 
and express so-called fibroblast activation 
markers such as α-smooth muscle actin 
(αSMA) (56).
A subsequent study identified fibro-
blast subtypes in the mouse dermis accord-
ing to the expression of Engrailed-1 (En1) 
and CD26. The authors found that the 
CD26+En1+ population is responsible for 
dermal development and fibrosis and also 
contributes to the cancer stroma (57). The 
differences observed between these two 
studies with respect to CD26 expression 
highlight that the expression of lineage 
markers can be dynamic, varying according 
to stage of development even where lineage 
identity is maintained. Further studies are 
needed to establish whether similar lineages 
are present in the human dermis.
Additional fibroblast subtypes present  
within the dermis
Two separate populations of fibroblasts are associated with hair 
follicles (Figure 1). Hair follicle dermal papilla (FDP) fibroblasts 
play a central role in the development of hair and the coordination 
of the hair cycle (58, 59). Both primary and cultured FDP fibro-
blasts have the capability to induce the development of epithelial 
hair follicle elements at ectopic sites in the skin (60–63). In the 
mouse, dermal papillae are derived from a common fibroblast pro-
genitor that is present at E12.5 (56). Lineage tracing of Sox2-Cre 
FDP fibroblasts reveals that these cells have only a minority con-
tribution to wound healing (64). However, there is some evidence 
that in certain circumstances dermal papilla (FDP) fibroblasts can 
differentiate to other cell types, including nerve and cartilage (65). 
A second population of hair follicle–associated fibroblasts, dermal 
sheath (DS) fibroblasts, encapsulate the hair shaft external to epi-
thelial components of the hair follicle, from which they are sepa-
rated by a basement membrane termed the glassy membrane.
A number of markers have been described for human and 
mouse FDP and DS fibroblasts, including CD133 (in human and 
mouse) and nonspecific alkaline phosphatase (in human) (66–68). 
Marker expression changes according to stage of the hair cycle 
(69–72) and, in the mouse, depends on the hair follicle type, with 
Immunohistochemical studies have demonstrated differ-
ences in the expression of collagen subtypes and proteoglycans 
between papillary and reticular dermis (45, 48–50), although 
interpretation of these studies is complicated by differences in 
the density of fibroblasts and ECM elements in different regions 
of the dermis. Papillary and reticular fibroblasts can be isolat-
ed by explant culture of mechanically sectioned (dermatomed) 
human dermis. Explant fibroblast cultures derived from these 
layers exhibit differences in a number of parameters, including 
rate of cell division, contraction, and the expression of various 
collagens and proteoglycans (5, 51, 52). Cultured fibroblasts 
derived from the papillary dermis support the formation of a 
normal stratified epidermis in three-dimensional organotypic 
culture more effectively than fibroblasts from the reticular der-
mis (47, 53, 54). This may reflect differences in both secreted 
factors and ECM elements (55); however, as noted above, these 
observations are potentially confounded by selection inherent in 
explant cultures and by contamination with other fibroblast sub-
populations, including pericytes.
More recently, we and others demonstrated the presence 
of functional dermal fibroblast subtypes in the mouse dermis. 
Using PDGFRα as a pan-fibroblast marker, linage tracing exper-
iments revealed that dermal fibroblast populations including 
Figure 3. Mouse dermal fibroblast lineages. Dermal fibroblasts derive from common fibroblast pro-
genitor cells and differentiate into specific lineages by postnatal day 2 (P2). These subtypes display 
distinct functions. For example, papillary fibroblasts are essential in the coordination of the hair cycle 
and the formation of hair follicles after injury, and reticular fibroblasts mediate early wound repair 
responses. Adapted with permission from Trends in Cell Biology (6). APM, arrector pili muscle.
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to anterior scalp (90), and FDP fibroblasts maintain hair induction 
capability for both mouse and human, at least for early passages in 
culture (71, 91, 92).
In most cases, the details of transcriptional regulatory net-
works governing specification of fibroblast subtypes are unknown. 
However, the identity of certain key transcriptional regulators 
has been established. Sox2 appears to play a key role in the spec-
ification of certain hair follicle types within the mouse dermis. 
Cre-mediated ablation of Sox2 in FDP cells leads to a reduction 
in awl/auchene hairs and an increase in zigzag hairs in mice (93). 
Conversely, expression of Sox18 is required for the formation of 
zigzag hairs (94). Interestingly, Sox2+ FDP fibroblasts maintain 
their identity in culture (71), consistent with intrinsic differences 
in cellular identity.
Extrinsic factors governing fibroblast  
cellular identity
Extrinsic factors governing cell fate include cell-cell contact, 
secreted signaling factors, and interactions with ECM elements. 
The exposure of a particular cell to these influences will depend 
on spatial context within the tissue. Coculture experiments reveal 
that keratinocytes instruct fibroblasts to produce a range of cyto-
kines, including IL-6 and FGF7 (95, 96). IL-1 has been identified 
as an inducing factor in these coculture experiments (96, 97). 
Conversely, factors secreted by fibroblasts influence the growth 
and differentiation of keratinocytes, indicating reciprocal cell-
cell interaction (98). Additionally, ECM context has an import-
ant impact on fibroblast cellular identity. Fibroblasts cultured 
as a monolayer exhibit differences in collagen expression and 
morphology in comparison with fibroblasts in three-dimension-
al culture. There are also differences observed between collagen 
and fibrin gels (99–101). An instructive role of ECM elements in 
cellular identity is supported by tissue engineering strategies in 
which the ECM of decellularized organs is repopulated with cells 
(102, 103). While the full details of these interactions remain to be 
discovered, it is possible that a dynamic interplay between ECM 
signaling and production is important in the maintenance of fibro-
blast cellular identity in tissues.
With regard to specific signaling pathways that are implicated 
in the regulation of fibroblast cell identity, the emerging picture is 
of a complex interplay of multiple signaling pathways that syner-
gistically regulate fibroblast identity and function within the der-
mis. Preeminent among these is the Wnt pathway. Epidermal Wnt 
signaling is required for hair follicle morphogenesis (92, 104). Epi-
dermal overexpression of the Wnt downstream effector β-catenin 
in all basal epidermal keratinocytes via the keratin 14 (K14) pro-
moter leads to de novo hair follicle morphogenesis in adult skin; 
this is accompanied by extensive remodeling of the dermis ECM 
(105). These effects are mediated by both TGF-β and Hedgehog 
signaling (106) and influence the lower and upper dermal fibro-
blast lineages, respectively. Pharmacological deletion or genetic 
ablation of these pathways prevents the response to epidermal 
Wnt/β-catenin overexpression (106).
Other signaling pathways, including secreted BMPs and 
insulin-like growth factors, play a role in mediating the effects of 
keratinocyte-specific β-catenin expression, leading to an increase 
in adipogenesis. Conversely, inhibition of Wnt/β-catenin signal-
Sox2 expressed in all dermal papillae from E16.5 but confined 
to guard, awl, and auchene hairs from E18.5 (70). Variation has 
also been observed in the expression of markers for hair follicles 
according to anatomical site of origin; for example, the expression 
of androgen receptors is higher in regions of the scalp that are sus-
ceptible to male pattern hair loss (73).
Additional populations of fibroblasts within the dermis 
include pericytes, preadipocytes, and myofibroblasts. As dis-
cussed in detail above, pericytes are associated with and encircle 
vascular channels (34, 35). Wound healing in the adult organism 
is characterized by the formation of an ECM-rich scar that lacks 
normal cutaneous appendages such as hair and sweat glands (74). 
Wounding leads initially to the formation of a fibrin-rich plug, 
followed by the accumulation of leukocytes and the migration 
of αSMA+ myofibroblasts from adjacent dermis and underlying 
adipose tissue into the wound (75–78). Subsequently, the infiltrat-
ing αSMA+ fibroblasts develop a contractile phenotype (79). Lin-
eage tracing in the mouse demonstrates that the initial wave of 
fibroblast migration is derived from lower-lineage (i.e., reticular) 
fibroblasts (56).
Preadipocytes are fibroblasts with the capacity to differenti-
ate to adipocytes. These are enriched in the lower dermis (80). In 
humans, they express the CD36 cell surface marker (81). Lineage 
tracing of preadipocytes with Cre-labeled adiponectin reveals 
that preadipocytes proliferate and mature adipocytes migrate to 
contribute to wound repair (82). Preadipocytes are differentiated 
from other fibroblasts by the expression of ZFP423, a zinc finger 
transcription factor (83). Peroxisome proliferator–activated recep-
tor gamma 2 (PPARγ2) is a master transcriptional regulator of the 
subsequent adipogenic differentiation program (84).
Interestingly, a recent study has demonstrated that myofi-
broblasts have the capacity to transdifferentiate to adipocytes 
in response to bone morphogenetic protein (BMP) signals aris-
ing from hair follicles in the healing wound (85), suggesting that 
preadipocytes are not the only cell type that can give rise to mature 
fat cells in the dermis.
Intrinsic mechanisms specifying fibroblast 
cellular identity
Cellular identity is determined both by intrinsic mechanisms, 
including transcriptional regulatory networks (86) and epigene-
tic processes, and by extrinsic factors, including cell-cell signal-
ing, soluble signaling mediators, or ECM elements. A key role for 
intrinsic mechanisms in the specification of fibroblast identity is 
demonstrated by classic heterotopic transplantation experiments, 
which show an instructive role of mesenchyme in specifying the 
identity of overlying epithelial tissues. The culture of dental epi-
thelium from chick embryos overlying dermal mesenchyme led 
to the development of epidermis including cutaneous appendages 
(87). Similar results were seen with the ability of wing mesenchyme 
to induce the development of feathers in heterotopic tissues (88).
Consistent with these findings, fibroblasts derived from palms 
and soles are able to induce the expression of keratin 9 in nonpal-
moplantar keratinocytes, but this is not the case for fibroblasts 
derived from nonpalmoplantar sites (89). Furthermore, studies of 
hair transplantation demonstrate that follicles taken from the pos-
terior scalp retain their developmental identity when transplanted 
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ing in the epidermis impairs adipogenesis (107). Interestingly, it 
appears that the consequences of Wnt/β-catenin are cell type–spe-
cific. β-Catenin stabilization in dermal fibroblasts during develop-
ment leads to fibrosis and impairs adipogenesis (108). Wnt/β-cat-
enin expression in the adult dermis inhibits de novo hair follicle 
formation in healing wounds, and postnatal ablation of β-catenin 
in dermal fibroblasts enhances new hair formation (109).
Additional signaling pathways that have been implicated in 
the regulation of dermal fibroblasts include the Notch pathway, 
which has a role in the regulation of inflammation and hair folli-
cle morphogenesis (110, 111). TGF-β signaling also plays a key role 
in wound healing and scar formation (3). BMP signaling has been 
implicated in the regulation of hair follicle morphogenesis (112–
114). Furthermore, BMP signaling is required for the transdiffer-
entiation of myofibroblasts to adipocytes in healing wounds (85).
Dysregulation of Wnt signaling is observed in a number of 
conditions that are characterized by aberrant or excessive fibrosis. 
The profibrotic effects of TGF-β are mediated through canonical 
Wnt signaling via a decreased expression of the Wnt antagonist 
Dickkopf-1 (115). A role for Wnt signaling has also been seen in 
renal fibrosis (116), idiopathic pulmonary fibrosis (117), and the 
increased fibrosis that is observed to accompany muscle regener-
ation with aging (118).
Fibroblasts play a critical role in maintaining the structur-
al integrity of the dermis. To fulfill this function, there must exist 
a mechanism for fibroblasts to adapt and respond to mechanical 
stress. The details of these processes are emerging. YAP signaling 
via the Hippo pathway has been implicated in the regulation of ECM 
stiffness (119). Furthermore, a role for focal adhesion kinase (FAK) 
signaling has been demonstrated in the response of wound repair 
to mechanical stress (22). FAK signaling is triggered by cutaneous 
injury and signals through ERK to induce the expression of mono-
cyte chemoattractant protein-1 (MCP-1), a profibrotic chemokine.
Therapeutic implications
The emerging concept that mammalian tissues, such as the der-
mis, contain fibroblasts with differing functional identities has 
profound implications for the understanding of a wide range of 
pathological states, including diseases characterized by excessive 
fibrosis such as scarring, scleroderma, cancer, and potentially 
including chronological aging. It is likely that fibroblast subtypes 
identified in mice will be conserved in the human, and this is the 
subject of ongoing investigation.
In contrast to adult mammals, wounds in the fetus heal with-
out scarring (120, 121). An understanding of the role of fibroblast 
subtypes in this process may suggest strategies to reduce scarring 
in adult organisms. Scar-free healing is observed up until 24 weeks 
of human gestation and is conserved across many mammalian spe-
cies (121). Studies examining human fetal skin grafts to immuno-
deficient mice indicate that this is an intrinsic property of the fetal 
skin (122), possibly mediated by differences in the fibroblast sub-
types present. Interestingly, epidermal activation of canonical Wnt 
signaling in the basal layer of mouse epidermis leads to remodeling 
of the adult dermis to a neonatal-like state with formation of new 
hair follicles (105). Wnt signaling is also required for regeneration 
of nails and digits in neonatal mice (29, 123) and may contribute to 
differences in wound healing between the fetus and adult.
The involvement of specific fibroblast lineages may have par-
ticular relevance to diseases characterized by excessive fibrosis 
and scarring such as scleroderma, keloids, graft-versus-host dis-
ease, and pulmonary fibrosis. Keloidal scaring is characterized 
by excessive fibroblast proliferation and ECM deposition (124, 
125), and keloid-derived fibroblasts exhibit differences in gene 
expression and behavior in culture compared with fibroblasts 
from healthy dermis (126, 127). It has been proposed that these 
disease-associated alterations in fibroblast behavior reflect epi-
genetic alterations in gene expression patterns, and in keeping 
with this, fibroblasts in rheumatoid arthritis exhibit differences 
in DNA methylation and histone acetylation (128). Fibroblasts 
derived from patients with scleroderma exhibited differences 
in methylation of the FLI1 promoter (129). Epigenetic differenc-
es were also observed between keloidal and control fibroblasts 
(130). Histone deacetylase inhibitors were able to normalize to 
some extent the differences in gene expression seen with fibro-
blasts derived from the airways of patients with severe pulmo-
nary hypertension (131).
Epithelial tumors consist of a mixture of epithelial elements, 
fibroblasts, and ECM components. Cancer-associated fibroblasts 
(CAFs) play an important role in evolution of solid tumors. There is 
an extensive crosstalk between CAFs and the epithelial elements 
of tumors (132), wherein fibroblasts associated with later stages 
of malignancy exhibit different phenotypes. Interestingly, CAFs 
exhibit an increased expression of αSMA (1), which may reflect 
alterations in the composition of fibroblast subtypes. YAP signal-
ing as a consequence of mechanical stress also plays an important 
role in remodeling of the ECM that accompanies carcinogenesis. 
There is evidence for heterogeneity of CAFs (133), but the extent 
to which these differences reflect fibroblast subtypes present in 
normal tissue remains to be determined, and further characteri-
zation of fibroblast subtypes may increase our understanding of 
these questions.
Aging is associated with characteristic changes in the struc-
ture of the dermis, including dermal thinning and flattening of 
the dermal-epidermal junction, with loss of the normal rete ridg-
es (134, 135). Interestingly, this appears to preferentially affect 
the papillary dermis: alterations in the behavior of papillary der-
mal fibroblasts derived from older donors have been observed 
in three-dimensional cultures (136). Changes are also prominent 
in other components of connective tissue such as the large blood 
vessels. In the skin, proliferation of fibroblasts occurs during 
mouse embryonic development; however, subsequent growth of 
the animal is not associated with further fibroblast proliferation 
and is instead achieved simply by an increase in the ECM volume 
between adjacent fibroblasts (109). This is consistent with the 
observation that the rate of fibroblast division in the adult dermis 
is very low in the steady state (137). It may be that during aging 
this relative paucity of fibroblasts in the adult is insufficient to 
maintain the structural integrity of the ECM. Alternatively, it may 
be that there are age-associated alterations in the composition of 
fibroblast subtypes within the dermis.
A goal of regenerative medicine is the restoration of normal 
form and function either via cellular therapies in vivo or by the 
reconstitution of functional organs ex vivo. Efforts to accomplish 
the latter have led to attempts to reconstitute intact organs via the 
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reintroduction of cellular populations to decellularized ECM tem-
plates (102, 103). This has proven challenging, and future efforts 
may be informed by a better understanding of the fibroblast sub-
types present in these tissues. There have also been attempts to 
prepare organotypic skin substitutes comprising both fibroblasts 
and keratinocytes for grafting onto chronic wounds or other sites 
(138). It is recognized that, in vitro, fibroblasts derived from the 
upper dermis better support the formation of a structurally and 
functionally normal epidermis (47, 53, 54), and it is likely that an 
understanding of fibroblast subtypes present in human dermis will 
facilitate the prospective isolation of cells for the repopulation of 
dermal templates of this nature.
A detailed characterization of fibroblast subtypes in the human 
in combination with an understanding of the differential contribu-
tion of these subtypes to human disease may offer novel strategies 
for the treatment of diseases. In this context, it could be envisaged 
that the action of deleterious fibroblast subtypes could be inhibit-
ed, perhaps via inhibition of signaling pathways specific to these 
subtypes or via monoclonal antibody–mediated deletion. In sup-
port of this concept, experimentally reducing the number of fibro-
blasts during wound healing in the mouse can reduce the degree 
of fibrosis (38). Alternatively, beneficial subtypes may be expanded 
ex vivo, perhaps via manipulation of cell signaling pathways. Trials 
of fibroblast cell therapy are already under way for the treatment of 
poorly healing ulcers (139) and epidermolysis bullosa (140). Nota-
bly, papillary fibroblasts appear to be more effective when used in 
the construction of tissue-engineered skin substitutes (141).
Conclusions and outstanding questions
The emerging picture from the research outlined in this Review is 
that fibroblasts represent a family of related cell types with differ-
ing functions in the formation and maintenance of ECM in connec-
tive tissues and play a key role in coordinating the function of other 
cell types within the tissue. The understanding of fibroblast hetero-
geneity is most advanced for the mammalian dermis, because this 
is a particularly tractable tissue for experimental studies. However, 
it is probable that these principles are common to other vertebrate 
tissues including the intestine, lung, heart, and muscle.
Many details of the mechanisms that establish and maintain 
vertebrate cellular identity remain unclear, and the outstanding 
questions in the field of fibroblast cell biology reflect this. It is pres-
ently unclear to what extent differences in fibroblast cellular iden-
tity are specified intrinsically versus reflecting a consequence of 
spatial context within the tissue such as cell-cell contacts and sig-
naling. Intrinsically specified differences in fibroblast functional 
identity likely reflect a combination of transcriptional regulatory 
networks with epigenetic mechanisms. At present, in most cases 
we do not know the full details of the transcriptional regulatory 
networks that dictate the identity of fibroblast subtypes.
The importance of extrinsic signals in the maintenance of 
cellular identity is of particular relevance to the ex vivo expansion 
of fibroblasts in culture. There is evidence that fibroblasts exhibit 
a significant shift in the expression of cell surface markers in the 
transition to cell culture (142). This may reflect an influence of 
extrinsic signals that are required for the maintenance of fibroblast 
cell identity, which will be lost on transition to culture. Further-
more, since minimal fibroblast cell division occurs in vivo, it may 
be that the powerful mitogenic stimuli encountered in cell culture 
lead to dramatic alterations in cellular identity. These issues are of 
considerable relevance to efforts to develop fibroblast therapies, 
particularly as ex vivo strategies will have a higher complexity for 
regulatory approval and likely a higher cost. Furthermore, they 
are important for the study of human disease, since many studies 
have sought to infer disease mechanisms through the study of cul-
tured patient-derived fibroblasts.
Another unresolved question is the degree of plasticity that 
exists in fibroblast cell identity — can one type of fibroblast dif-
ferentiate to another given the appropriate stimuli, or is there is a 
hierarchy of fibroblasts exhibiting progressively restricted differ-
entiation potential? To what extent do mesenchymal stem/stro-
mal cells correspond to fibroblast subtypes present elsewhere in 
the body, and do they have the capacity to differentiate into other 
fibroblast subtypes and incorporate into tissues?
It is not clear to what extent fibroblast subtypes identified in 
the mouse dermis are conserved in the human. To understand 
the role that fibroblast subtypes play in human disease, markers 
that permit subtype identification in human histological sections 
and permit the prospective isolation of these subtypes by flow 
cytometry will be required. Previous studies of human dermis 
have attempted to define markers that distinguish fibroblasts 
cultured separately from the papillary and reticular dermis (47). 
However, this approach has not yielded cell surface markers that 
permit the prospective isolation of fibroblast subpopulations 
directly from the skin. These issues are areas of active investi-
gation, and it is likely that recent advancements in the area of 
single-cell-based transcriptional and epigenetic analysis will cat-
alyze a greater understanding.
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